KB
Kennedy Brendan
Director
OFFICERM
Insider track record
ExecutiveAcross 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Kennedy Brendan, Director. Insider active across 3 companies, notably Tilray, Inc.. In total, 17 reports have been published. Split: 0 buy · 13 sells. Total volume traded: €30.8m. History available since 3 May 2021. The latest transaction was disclosed on 7 November 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations17 total
350,000 shares@ US$3.779322.6% of flowClass 2 Common StockSEC:0001209191-22-056279:0
350,000 shares@ US$2.909717.4% of flowClass 2 Common StockSEC:0001209191-22-053098:0
50,000 shares@ US$1.502841.2% of flowCommon StockSEC:0001209191-22-051969:0
350,000 shares@ US$3.222919.3% of flowClass 2 Common StockSEC:0001209191-22-049207:0
50,000 shares@ US$2.214358.8% of flowCommon StockSEC:0001209191-22-046931:0
350,000 shares@ US$3.911722.7% of flowClass 2 Common StockSEC:0001209191-22-045033:0
350,000 shares@ US$3.090517.9% of flowClass 2 Common StockSEC:0001209191-22-041514:0
300,000 shares@ US$14.08090.56% mcap13.9% of flowClass 2 Common StockSEC:0001140361-21-027415:0
300,000 shares@ US$14.080913.9% of flowClass 2 Common StockSEC:0001140361-21-027415
223,711 shares@ US$14.495810.7% of flowClass 2 Common StockSEC:0001140361-21-024836
223,711 shares@ US$14.49580.43% mcap10.7% of flowClass 2 Common StockSEC:0001140361-21-024836:0
400,000 shares@ US$17.966623.6% of flowClass 2 Common StockSEC:0001140361-21-022174
400,000 shares@ US$17.96660.95% mcap23.6% of flowClass 2 Common StockSEC:0001140361-21-022174:0
32,148 shares@ US$16.991.8% of flowClass 2 Common StockSEC:0001140361-21-016872
32,148 shares@ US$16.990.071% mcap1.8% of flowClass 2 Common StockSEC:0001140361-21-016872:0
73,954 sharesClass 2 Common StockSEC:0001140361-21-016050
73,954 sharesClass 2 Common StockSEC:0001140361-21-016050:0
About Kennedy Brendan
Brendan Kennedy is a Board Member at Tilray, Inc. He contributes to the strategic direction of the company, bringing his expertise in the consumer products and health sector.